Binbin Xu
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- RNA modifications and cancer
- Cancer-related gene regulation
- Circular RNAs in diseases
- RNA Research and Splicing
- Epigenetics and DNA Methylation
- Bone Metabolism and Diseases
Papers in
-
- RNA modifications and cancer 5
- RNA Research and Splicing 3
- Metabolism, Diabetes, and Cancer 1
-
- Cancer-related molecular mechanisms research 5
- MicroRNA in disease regulation 1
- Co-authors
- Yangyang Xie (3 shared papers)Hua Yu (3 shared papers)Xiaoyu Dai (2 shared papers)Wu Zhou (2 shared papers)Huiqin Zhang (2 shared papers)Kaiyue Wang (1 shared paper)Qun Luo (1 shared paper)Kedan Cai (1 shared paper)
In The Last Decade
Binbin Xu
18 papers receiving 467 citations
Peers
Comparison fields: 5 of 83
- Cancer Research 163
- Molecular Biology 324
- Molecular Medicine 18
- Aquatic Science 21
- Nephrology 20
Countries citing papers authored by Binbin Xu
This map shows the geographic impact of Binbin Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Binbin Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Binbin Xu more than expected).
Fields of papers citing papers by Binbin Xu
This network shows the impact of papers produced by Binbin Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Binbin Xu. The network helps show where Binbin Xu may publish in the future.
Co-authors
The 25 scholars most cited alongside Binbin Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 72 | |
| 2 | 2020 | 48 | |
| 3 | 2016 | 47 | |
| 4 | 2016 | 45 | |
| 5 | 2019 | 44 | |
| 6 | 2015 | 39 | |
| 7 | 2021 | 38 | |
| 8 | 2023 | 29 | |
| 9 | 2019 | 25 | |
| 10 | 2021 | 21 | |
| 11 | 2021 | 19 | |
| 12 | 2022 | 16 | |
| 13 | 2023 | 13 | |
| 14 | 2018 | 5 | |
| 15 | 2023 | 3 | |
| 16 | 2023 | 2 | |
| 17 | 2025 | 1 | |
| 18 | 2025 | 1 |
About Binbin Xu
Binbin Xu is a scholar working on Molecular Biology, Cancer Research, Surgery, Immunology and Epidemiology, having authored 18 papers that have together received 468 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (5 papers), RNA modifications and cancer (5 papers), RNA Research and Splicing (3 papers), Autophagy in Disease and Therapy (2 papers), Pharmacological Effects of Medicinal Plants (1 paper), MicroRNA in disease regulation (1 paper), Metabolism, Diabetes, and Cancer (1 paper) and Multilevel Inverters and Converters (1 paper). The work is most often cited by research in Cancer Research (163 citations), Molecular Biology (324 citations), Molecular Medicine (18 citations), Aquatic Science (21 citations) and Nephrology (20 citations). Binbin Xu has collaborated with scholars based in China, Sweden and Germany. Frequent co-authors include Yangyang Xie, Hua Yu, Xiaoyu Dai, Wu Zhou, Huiqin Zhang, Kaiyue Wang, Qun Luo, Kedan Cai, Yixin Wu and Weiwei Tang. Their work appears in journals such as ACS Chemical Neuroscience, Scientific Reports, Molecular Oncology, Nature Communications and Technology in Cancer Research & Treatment.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.